ČULENOVÁ, Marie, Alice SYCHROVÁ, S. T. S. HASSAN, K. BERCHOVA-BIMOVA, P. SVOBODOVA, A. HELCLOVA, H. MICHNOVA, J. HOSEK, H. VASILEV, Pavel SUCHÝ, Gabriela KUZMÍNOVÁ, Emil ŠVAJDLENKA, Jan GAJDZIOK, Alois ČÍŽEK, Václav SUCHÝ a Karel ŠMEJKAL. Multiple In vitro biological effects of phenolic compounds from Morus alba root bark. JOURNAL OF ETHNOPHARMACOLOGY. CLARE: ELSEVIER IRELAND LTD, 2020, roč. 248, č. 112296, s. 1-12. ISSN 0378-8741. Dostupné z: https://dx.doi.org/10.1016/j.jep.2019.112296.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Multiple In vitro biological effects of phenolic compounds from Morus alba root bark
Autoři ČULENOVÁ, Marie (203 Česká republika, garant, domácí), Alice SYCHROVÁ (203 Česká republika, domácí), S. T. S. HASSAN, K. BERCHOVA-BIMOVA, P. SVOBODOVA, A. HELCLOVA, H. MICHNOVA, J. HOSEK, H. VASILEV, Pavel SUCHÝ (203 Česká republika, domácí), Gabriela KUZMÍNOVÁ (203 Česká republika, domácí), Emil ŠVAJDLENKA (203 Česká republika, domácí), Jan GAJDZIOK (203 Česká republika, domácí), Alois ČÍŽEK (203 Česká republika, domácí), Václav SUCHÝ (203 Česká republika, domácí) a Karel ŠMEJKAL (203 Česká republika, domácí).
Vydání JOURNAL OF ETHNOPHARMACOLOGY, CLARE, ELSEVIER IRELAND LTD, 2020, 0378-8741.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.360
Kód RIV RIV/00216224:14160/20:00118192
Organizační jednotka Farmaceutická fakulta
Doi http://dx.doi.org/10.1016/j.jep.2019.112296
UT WoS 000503312800025
Klíčová slova anglicky Antiviral; Antibacterial; Anti-inflammatory; Docking; Mulberry; Phenolic
Štítky rivok, ÚFT, ÚFTo, ÚPL
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Hana Hurtová, učo 244985. Změněno: 24. 2. 2021 08:19.
Anotace
Ethnopharmacological relevance: Morus alba L. is used in traditional Chinese medicine for the treatment of various diseases, including bacterial infections and inflammation. As a rich source of phenolic compounds, the plant is an object of many phytochemical and pharmacological studies. Aim of the study: The aim of the study was to isolate and evaluate possible parallel antiviral, antibacterial, and anti-inflammatory activities of phenolic mulberry compounds. Materials and methods: Extensive chromatographic separation of mulberry root bark extract and in vitro biological screening of 26 constituents identified promising candidates for further pharmacological research. Selected compounds were screened for anti-infective and anti-inflammatory activities. Antiviral activity was determined by the plaque number reduction assay and by the titer reduction assay, antibacterial using broth microdilution method, and anti-inflammatory activity using COX Colorimetric inhibitor screening assay kit. One compound was evaluated in vivo in carrageenan-induced paw-edema in mice. Results: Five prenylated compounds 1, 2, 8, 9, and 11, together with a simple phenolic ester 13, exhibited inhibitory activity against the replication of herpes simplex virus 1 (HSV-1) or herpes simplex virus 2 (HSV-2), with IC50 values ranging from 0.64 to 1.93 mu g/mL, and EC50 values 0.93 and 1.61 mu g/mL. Molecular docking studies demonstrated the effects of the active compounds by targeting HSV-1 DNA polymerase and HSV-2 protease. In antibacterial assay, compounds 1, 4, 11, and 17 diminished the growth of all of the Gram-positive strains tested, with MIC values of 1-16 mu g/mL. The anti-inflammatory ability of several compounds to inhibit cyclooxygenase 2 (COX-2) was tested in vitro, and compound 16 displayed greater activity than the indomethacin, positive control. Mulberrofuran B (11) showed anti-inflammatory activity in vivo against carrageenan-induced paw-edema in mice. Conclusions: Experimental investigation showed promising antiviral, antibacterial, and/or anti-inflammatory activities of the phenolic mulberry constituents, often with multiple inhibitory effects that might be used as a potential source of new medicine.
VytisknoutZobrazeno: 26. 4. 2024 06:04